GSK-2126458
-
Catalog number1961-1
-
PricePlease ask
-
Size1 mg
-
-
Alternative_name2,4-Difluoro-N-{2-(methyloxy)-5-[4-(4-pyridazinyl)-6-quinolinyl]-3-pyridinyl}benzenesulfonamide
-
DescriptionCell-permeable. A highly potent, pan phosphoinositide 3-kinase (PI 3-K) family kinase inhibitor with biochemical Ki’s of 0.019 nM (PI 3-K⍺), 0.13 nM (PI 3-Kβ), 0.024 nM (PI 3-Kδ), 0.06 nM (PI 3-Kɣ), 0.18 nM (mTORC1), and 0.3 nM (mTORC2). In vivo, GSK2126458 displays anti-tumor activity in both pharmacodynamic and tumor growth efficacy models.
-
CAS Number1086062-66-9
-
Structure AvailableYes
-
Salt FormNo
-
Molecular FormulaC₂₅H₁₇F₂N₅O₃S
-
Molecular Weight505.5
-
Cell PermeableYes
-
Purity≥98% by HPLC
-
SolubilitiesDMSO (~ 5 mg/ml)
-
HandlingProtect from light and air
-
Tag LineA PI3 Kinase inhibitor
-
Storage Condition-20°C
-
Shipping Conditiongel pack
-
Shelf Life48 months
-
MDL NumberMFCD16038929
-
PubChem CID25167777
-
SMILESCOC1=C(C=C(C=N1)C2=CC3=C(C=CN=C3C=C2)C4=CN=NC=C4)NS(=O)(=O)C5=C(C=C(C=C5)F)F
-
InChiInChI=1S/C25H17F2N5O3S/c1-35-25-23(32-36(33,34)24-5-3-18(26)12-21(24)27)11-17(13-29-25)15-2-4-22-20(10-15)19(7-8-28-22)16-6-9-30-31-14-16/h2-14,32H,1H3
-
InChi KeyCGBJSGAELGCMKE-UHFFFAOYSA-N
-
MSDS AvailableYes
-
Gene target
-
Short nameGSK-2126458
-
Alternative nameGSK-2126458
-